HBK Sorce Advisory LLC Raises Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

HBK Sorce Advisory LLC grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 10.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,591 shares of the pharmacy operator’s stock after purchasing an additional 1,188 shares during the quarter. HBK Sorce Advisory LLC’s holdings in Walgreens Boots Alliance were worth $117,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. State Street Corp raised its position in shares of Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after buying an additional 2,185,950 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after buying an additional 817,762 shares during the period. Thompson Siegel & Walmsley LLC raised its position in shares of Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after buying an additional 934,754 shares during the period. Finally, Bank of New York Mellon Corp raised its position in shares of Walgreens Boots Alliance by 9.6% in the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock worth $50,684,000 after buying an additional 478,061 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $11.23 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05. The company’s 50-day simple moving average is $10.83 and its 200-day simple moving average is $9.76. The stock has a market capitalization of $9.70 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter last year, the company posted $0.66 earnings per share. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Evercore ISI increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Finally, Bank of America increased their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $11.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.